VAUGHAN, ON, Oct. 19 /CNW/ - Prism Medical Ltd. ("Prism") (PM:TSX-VEN) announced today that the directors have approved payment of a dividend of $0.075 per common share on November 5, 2009 to the shareholders of record on October 28, 2009.
Prism also announced today that the board of directors approved the appointment of Raymond James & Associates, Inc. to act as a financial advisor to the company. In such capacity, Raymond James & Associates, Inc. will independently assess the value of the company and review strategic alternatives with a view to increasing shareholder liquidity and maximizing shareholder value.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this press release.
SOURCE Prism Medical Ltd.
For further information: For further information: Andrew McIntyre, President, Chief Executive Officer and Chairman, Prism Medical Ltd., Tel: (416) 260-2145 ext. 235, Fax: (416) 260-9195, firstname.lastname@example.org, www.prismmedicalltd.com